glp-1 energy Introducing the Balanced Plant-Based Plate 🥗 GLP-1 therapy changes appetite, not nutritional needs. When patients eat less, nutritional quality becomes even more important. Smaller portions mean fewer opportunities to support protein Role of key hormones in

The CJC-1295 ipamorelin blend dosing describes, in preclinical research, the co-administration of two growth hormone secretagogues: a long-acting GHRH analog (CJC-1295) and a selective ghrelin-receptor agonist (Ipamorelin)

Half your plate as vegetables: leafy greens, broccoli, peppers, courgettes, tomatoes, and mushrooms

The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action

Ileal luminal perfusion of a 5% glucose dissolved in saline in rats induces a rapid rise (2-fold) in portal plasma GLP-1 in 30 min (Herrmann et al., 1995)

GLP-1 receptor agonists and next-generation incretin therapies

For a full list of fund holdings visit the fund page